NATCO PHARMA
|
NATCO PHARMA Last 5 Year Balance Sheet History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| EQUITY AND LIABILITIES | |||||
| Share Capital | ₹36 Cr | ₹36 Cr | ₹37 Cr | ₹37 Cr | ₹37 Cr |
| Equity - Authorised | ₹40 Cr | ₹40 Cr | ₹40 Cr | ₹40 Cr | ₹40 Cr |
| Equity - Issued | ₹36 Cr | ₹36 Cr | ₹37 Cr | ₹37 Cr | ₹37 Cr |
| Equity Paid Up | ₹36 Cr | ₹36 Cr | ₹37 Cr | ₹37 Cr | ₹37 Cr |
| Equity Shares Forfeited | - | - | - | - | - |
| Adjustments to Equity | - | - | - | - | - |
| Preference Capital Paid Up | - | - | - | - | - |
| Face Value | ₹2.00 | ₹2.00 | ₹2.00 | ₹2.00 | ₹2.00 |
| Share Warrants & Outstandings | - | - | - | ₹3.40 Cr | ₹18 Cr |
| Total Reserves | ₹7,571 Cr | ₹5,817 Cr | ₹4,837 Cr | ₹4,224 Cr | ₹4,068 Cr |
| Securities Premium | ₹1,202 Cr | ₹1,202 Cr | ₹1,407 Cr | ₹1,408 Cr | ₹1,392 Cr |
| Capital Reserves | ₹52 Cr | ₹52 Cr | ₹52 Cr | ₹52 Cr | ₹52 Cr |
| Profit & Loss Account Balance | ₹6,247 Cr | ₹4,466 Cr | ₹3,292 Cr | ₹2,667 Cr | ₹2,568 Cr |
| General Reserves | ₹60 Cr | ₹60 Cr | ₹60 Cr | ₹60 Cr | ₹60 Cr |
| Other Reserves | ₹12 Cr | ₹39 Cr | ₹27 Cr | ₹38 Cr | ₹-3.20 Cr |
| Reserve excluding Revaluation Reserve | ₹7,571 Cr | ₹5,817 Cr | ₹4,837 Cr | ₹4,224 Cr | ₹4,068 Cr |
| Revaluation reserve | - | - | - | - | - |
| Shareholder's Funds | ₹7,607 Cr | ₹5,853 Cr | ₹4,874 Cr | ₹4,264 Cr | ₹4,122 Cr |
| Minority Interest | ₹5.30 Cr | - | - | - | ₹1.80 Cr |
| Long-Term Borrowings | - | - | - | - | - |
| Secured Loans | - | - | - | - | - |
| Non Convertible Debentures | - | - | - | - | - |
| Converible Debentures & Bonds | - | - | - | - | - |
| Packing Credit - Bank | - | - | - | - | - |
| Inter Corporate & Security Deposit | - | - | - | - | - |
| Term Loans - Banks | - | - | - | - | - |
| Term Loans - Institutions | - | - | - | - | - |
| Other Secured | - | - | - | - | - |
| Unsecured Loans | - | - | - | - | - |
| Fixed Deposits - Public | - | - | - | - | - |
| Loans and advances from subsidiaries | - | - | - | - | - |
| Inter Corporate Deposits (Unsecured) | - | - | - | - | - |
| Foreign Currency Convertible Notes | - | - | - | - | - |
| Long Term Loan in Foreign Currency | - | - | - | - | - |
| Loans - Banks | - | - | - | - | - |
| Loans - Govt. | - | - | - | - | - |
| Loans - Others | - | - | - | - | - |
| Other Unsecured Loan | - | - | - | - | - |
| Deferred Tax Assets / Liabilities | ₹-50 Cr | ₹-19 Cr | ₹12 Cr | ₹30 Cr | ₹41 Cr |
| Deferred Tax Assets | ₹296 Cr | ₹228 Cr | ₹196 Cr | ₹128 Cr | ₹65 Cr |
| Deferred Tax Liability | ₹246 Cr | ₹209 Cr | ₹208 Cr | ₹158 Cr | ₹106 Cr |
| Other Long Term Liabilities | ₹9.20 Cr | ₹9.30 Cr | ₹2.80 Cr | ₹9.30 Cr | ₹2.00 Cr |
| Long Term Trade Payables | - | - | - | - | - |
| Long Term Provisions | ₹66 Cr | ₹71 Cr | ₹85 Cr | ₹96 Cr | ₹100 Cr |
| Total Non-Current Liabilities | ₹25 Cr | ₹61 Cr | ₹101 Cr | ₹135 Cr | ₹143 Cr |
| Current Liabilities | - | - | - | - | - |
| Trade Payables | ₹275 Cr | ₹236 Cr | ₹264 Cr | ₹162 Cr | ₹146 Cr |
| Sundry Creditors | ₹275 Cr | ₹236 Cr | ₹264 Cr | ₹162 Cr | ₹146 Cr |
| Acceptances | - | - | - | - | - |
| Due to Subsidiaries- Trade Payables | - | - | - | - | - |
| Other Current Liabilities | ₹239 Cr | ₹239 Cr | ₹227 Cr | ₹127 Cr | ₹100 Cr |
| Bank Overdraft / Short term credit | - | ₹15 Cr | ₹9.40 Cr | ₹17 Cr | ₹16 Cr |
| Advances received from customers | ₹83 Cr | ₹85 Cr | ₹86 Cr | ₹3.00 Cr | ₹1.30 Cr |
| Interest Accrued But Not Due | - | - | - | - | - |
| Share Application Money | - | - | - | - | - |
| Current maturity of Debentures & Bonds | - | - | - | - | - |
| Current maturity - Others | - | - | - | - | - |
| Other Liabilities | ₹156 Cr | ₹139 Cr | ₹132 Cr | ₹107 Cr | ₹82 Cr |
| Short Term Borrowings | ₹273 Cr | ₹363 Cr | ₹165 Cr | ₹404 Cr | ₹266 Cr |
| Secured ST Loans repayable on Demands | ₹182 Cr | ₹167 Cr | ₹75 Cr | ₹289 Cr | ₹128 Cr |
| Working Capital Loans- Sec | ₹182 Cr | ₹167 Cr | ₹75 Cr | ₹289 Cr | ₹128 Cr |
| Buyers Credits - Unsec | - | - | - | - | - |
| Commercial Borrowings- Unsec | - | - | - | - | - |
| Other Unsecured Loans | ₹-91 Cr | ₹29 Cr | ₹15 Cr | ₹-174 Cr | ₹9.00 Cr |
| Short Term Provisions | ₹157 Cr | ₹135 Cr | ₹27 Cr | ₹18 Cr | ₹14 Cr |
| Proposed Equity Dividend | - | - | - | - | - |
| Provision for Corporate Dividend Tax | - | - | - | - | - |
| Provision for Tax | ₹79 Cr | ₹32 Cr | ₹10 Cr | ₹0.90 Cr | ₹1.30 Cr |
| Provision for post retirement benefits | - | - | - | - | - |
| Preference Dividend | - | - | - | - | - |
| Other Provisions | ₹78 Cr | ₹103 Cr | ₹17 Cr | ₹17 Cr | ₹13 Cr |
| Total Current Liabilities | ₹944 Cr | ₹973 Cr | ₹683 Cr | ₹710 Cr | ₹526 Cr |
| Total Liabilities | ₹8,581 Cr | ₹6,887 Cr | ₹5,657 Cr | ₹5,109 Cr | ₹4,792 Cr |
| ASSETS | |||||
| Gross Block | ₹4,015 Cr | ₹3,603 Cr | ₹3,375 Cr | ₹3,127 Cr | ₹2,702 Cr |
| Less: Accumulated Depreciation | ₹1,267 Cr | ₹1,112 Cr | ₹948 Cr | ₹815 Cr | ₹679 Cr |
| Less: Impairment of Assets | ₹50 Cr | - | - | - | - |
| Net Block | ₹2,698 Cr | ₹2,491 Cr | ₹2,427 Cr | ₹2,312 Cr | ₹2,023 Cr |
| Lease Adjustment A/c | - | - | - | - | - |
| Capital Work in Progress | ₹225 Cr | ₹137 Cr | ₹64 Cr | ₹130 Cr | ₹223 Cr |
| Non Current Investments | ₹153 Cr | ₹96 Cr | ₹87 Cr | ₹104 Cr | ₹152 Cr |
| Long Term Investment | ₹153 Cr | ₹96 Cr | ₹87 Cr | ₹104 Cr | ₹152 Cr |
| Quoted | - | - | - | ₹40 Cr | ₹70 Cr |
| Unquoted | ₹153 Cr | ₹96 Cr | ₹87 Cr | ₹64 Cr | ₹82 Cr |
| Long Term Loans & Advances | ₹74 Cr | ₹113 Cr | ₹78 Cr | ₹72 Cr | ₹44 Cr |
| Other Non Current Assets | ₹161 Cr | ₹27 Cr | ₹0.30 Cr | ₹4.70 Cr | ₹4.30 Cr |
| Total Non-Current Assets | ₹3,311 Cr | ₹2,863 Cr | ₹2,657 Cr | ₹2,622 Cr | ₹2,447 Cr |
| Current Assets Loans & Advances | - | - | - | - | - |
| Currents Investments | ₹321 Cr | ₹444 Cr | ₹305 Cr | ₹204 Cr | ₹152 Cr |
| Quoted | ₹217 Cr | ₹144 Cr | ₹101 Cr | ₹82 Cr | ₹23 Cr |
| Unquoted | ₹104 Cr | ₹300 Cr | ₹204 Cr | ₹122 Cr | ₹129 Cr |
| Inventories | ₹766 Cr | ₹701 Cr | ₹743 Cr | ₹762 Cr | ₹798 Cr |
| Raw Materials | ₹234 Cr | ₹204 Cr | ₹222 Cr | ₹245 Cr | ₹342 Cr |
| Work-in Progress | ₹125 Cr | ₹102 Cr | ₹129 Cr | ₹175 Cr | ₹183 Cr |
| Finished Goods | ₹237 Cr | ₹238 Cr | ₹278 Cr | ₹206 Cr | ₹130 Cr |
| Packing Materials | ₹51 Cr | ₹42 Cr | ₹30 Cr | ₹31 Cr | ₹31 Cr |
| Stores  and Spare | ₹96 Cr | ₹78 Cr | ₹74 Cr | ₹97 Cr | ₹77 Cr |
| Other Inventory | ₹23 Cr | ₹36 Cr | ₹9.40 Cr | ₹8.50 Cr | ₹34 Cr |
| Sundry Debtors | ₹1,247 Cr | ₹1,189 Cr | ₹856 Cr | ₹621 Cr | ₹413 Cr |
| Debtors more than Six months | ₹19 Cr | ₹14 Cr | ₹20 Cr | ₹87 Cr | ₹33 Cr |
| Debtors Others | ₹1,247 Cr | ₹1,195 Cr | ₹852 Cr | ₹576 Cr | ₹395 Cr |
| Cash and Bank | ₹2,176 Cr | ₹953 Cr | ₹546 Cr | ₹206 Cr | ₹284 Cr |
| Cash in hand | ₹0.20 Cr | ₹0.30 Cr | ₹0.30 Cr | ₹0.40 Cr | ₹0.50 Cr |
| Balances at Bank | ₹2,176 Cr | ₹953 Cr | ₹546 Cr | ₹206 Cr | ₹283 Cr |
| Other cash and bank balances | - | - | - | - | - |
| Other Current Assets | ₹135 Cr | ₹100 Cr | ₹64 Cr | ₹88 Cr | ₹95 Cr |
| Interest accrued on Investments | ₹100 Cr | ₹66 Cr | ₹29 Cr | ₹25 Cr | ₹36 Cr |
| Interest accrued on Debentures | - | - | - | - | - |
| Deposits with Government | - | - | - | - | - |
| Interest accrued and or due on loans | - | - | - | - | - |
| Prepaid Expenses | ₹31 Cr | ₹29 Cr | ₹28 Cr | ₹33 Cr | ₹23 Cr |
| Other current_assets | ₹4.20 Cr | ₹4.20 Cr | ₹7.60 Cr | ₹30 Cr | ₹36 Cr |
| Short Term Loans and Advances | ₹626 Cr | ₹638 Cr | ₹486 Cr | ₹606 Cr | ₹604 Cr |
| Advances recoverable in cash or in kind | ₹101 Cr | ₹111 Cr | ₹66 Cr | ₹100 Cr | ₹112 Cr |
| Advance income tax and TDS | - | - | - | - | - |
| Amounts due from directors | - | - | - | - | - |
| Due From Subsidiaries | - | - | - | - | - |
| Inter corporate deposits | - | - | - | - | - |
| Corporate Deposits | - | - | - | - | - |
| Other Loans & Advances | ₹525 Cr | ₹528 Cr | ₹420 Cr | ₹506 Cr | ₹491 Cr |
| Total Current Assets | ₹5,270 Cr | ₹4,024 Cr | ₹3,000 Cr | ₹2,487 Cr | ₹2,345 Cr |
| Net Current Assets (Including Current Investments) | ₹4,327 Cr | ₹3,051 Cr | ₹2,317 Cr | ₹1,776 Cr | ₹1,819 Cr |
| Miscellaneous Expenses not written off | - | - | - | - | - |
| Total Assets | ₹8,581 Cr | ₹6,887 Cr | ₹5,657 Cr | ₹5,109 Cr | ₹4,792 Cr |
| Contingent Liabilities | ₹3.00 Cr | ₹0.40 Cr | ₹15 Cr | ₹8.00 Cr | ₹1.20 Cr |
| Total Debt | ₹273 Cr | ₹363 Cr | ₹165 Cr | ₹404 Cr | ₹266 Cr |
| Book Value | 424.97 | 326.99 | 267.06 | 233.44 | 224.88 |
| Adjusted Book Value | 424.97 | 326.99 | 267.06 | 233.44 | 224.88 |
Compare Balance Sheet of peers of NATCO PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| NATCO PHARMA | ₹16,173.6 Cr | 4.3% | 6% | -34.9% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹433,764.0 Cr | 2.8% | 6.7% | 2.8% | Stock Analytics | |
| DIVIS LABORATORIES | ₹170,489.0 Cr | 1.9% | -0.5% | 6.9% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹126,442.0 Cr | 0.1% | 3.4% | 15.8% | Stock Analytics | |
| CIPLA | ₹123,088.0 Cr | 1.8% | -3.2% | 2.1% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹105,162.0 Cr | 2.7% | 0.4% | 3.4% | Stock Analytics | |
NATCO PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| NATCO PHARMA | 4.3% |
6% |
-34.9% |
| SENSEX | 0.9% |
0.8% |
7.1% |
You may also like the below Video Courses